Atlas Trials

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up

Clinical trial NCT03090503 · UNKNOWN

Trial details

NCT number
NCT03090503
Sponsor
Fundación Marques de Valdecilla
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaPsychotic DisordersPsychosis
Start date
2014-06-01
Primary completion
2019-06-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.